BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 7891013)

  • 1. ETA and ETB endothelin receptors in human myometrium characterized by the subtype selective ligands BQ123, BQ3020, FR139317 and PD151242.
    Bacon CR; Morrison JJ; O'Reilly G; Cameron IT; Davenport AP
    J Endocrinol; 1995 Jan; 144(1):127-34. PubMed ID: 7891013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin receptors in human coronary artery and aorta.
    Bacon CR; Davenport AP
    Br J Pharmacol; 1996 Mar; 117(5):986-92. PubMed ID: 8851522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [125I]-PD151242: a selective ligand for endothelin ETA receptors in human kidney which localizes to renal vasculature.
    Davenport AP; Kuc RE; Hoskins SL; Karet FE; Fitzgerald F
    Br J Pharmacol; 1994 Dec; 113(4):1303-10. PubMed ID: 7534185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human endothelin receptors characterized using reverse transcriptase-polymerase chain reaction, in situ hybridization, and subtype-selective ligands BQ123 and BQ3020: evidence for expression of ETB receptors in human vascular smooth muscle.
    Davenport AP; O'Reilly G; Molenaar P; Maguire JJ; Kuc RE; Sharkey A; Bacon CR; Ferro A
    J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S22-5. PubMed ID: 7509950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selectivity of [125I]-PD151242 for human, rat and porcine endothelin ETA receptors in the heart.
    Peter MG; Davenport AP
    Br J Pharmacol; 1995 Jan; 114(2):297-302. PubMed ID: 7881728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [125I]-PD151242: a selective radioligand for human ETA receptors.
    Davenport AP; Kuc RE; Fitzgerald F; Maguire JJ; Berryman K; Doherty AM
    Br J Pharmacol; 1994 Jan; 111(1):4-6. PubMed ID: 8012722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of endothelin receptors in human brain cortex, gliomas, and meningiomas.
    Harland SP; Kuc RE; Pickard JD; Davenport AP
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S408-11. PubMed ID: 8587429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the endothelin receptor selective agonist, BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart.
    Peter MG; Davenport AP
    Br J Pharmacol; 1996 Feb; 117(3):455-462. PubMed ID: 8821534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA sub-type.
    Davenport AP; O'Reilly G; Kuc RE
    Br J Pharmacol; 1995 Mar; 114(6):1110-6. PubMed ID: 7620699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin ETA receptor expression in human cerebrovascular smooth muscle cells.
    Yu JC; Pickard JD; Davenport AP
    Br J Pharmacol; 1995 Nov; 116(5):2441-6. PubMed ID: 8581282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney.
    Karet FE; Kuc RE; Davenport AP
    Kidney Int; 1993 Jul; 44(1):36-42. PubMed ID: 8355464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of [125I]-endothelin-1 and [125I]-BQ3020 binding to rat cerebellar endothelin receptors.
    Widdowson PS; Kirk CN
    Br J Pharmacol; 1996 Aug; 118(8):2126-30. PubMed ID: 8864551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin-1 binding to endothelin receptors in the rat anterior pituitary gland: possible formation of an ETA-ETB receptor heterodimer.
    Harada N; Himeno A; Shigematsu K; Sumikawa K; Niwa M
    Cell Mol Neurobiol; 2002 Apr; 22(2):207-26. PubMed ID: 12363203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of functional endothelin receptors in the porcine myometrium.
    Isaka M; Takaoka K; Yamada Y; Abe Y; Kitazawa T; Taneike T
    Peptides; 2000 Apr; 21(4):543-51. PubMed ID: 10822110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of two new ETB selective radioligands, [125I]-BQ3020 and [125I]-[Ala1,3,11,15]ET-1 in human heart.
    Molenaar P; Kuc RE; Davenport AP
    Br J Pharmacol; 1992 Nov; 107(3):637-9. PubMed ID: 1472961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of [125I]-PD164333, an ETA selective non-peptide radiolabelled antagonist, in normal and diseased human tissues.
    Davenport AP; Kuc RE; Ashby MJ; Patt WC; Doherty AM
    Br J Pharmacol; 1998 Jan; 123(2):223-30. PubMed ID: 9489609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the binding of endothelin ETB selective ligands in human and rat heart.
    Russell FD; Davenport AP
    Br J Pharmacol; 1996 Oct; 119(4):631-6. PubMed ID: 8904635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of the rat cerebellar endothelin B (ETB) receptor using the novel agonist radioligand [125I]BQ3020.
    Jarvis MF; Assal AA; Gessner G
    Brain Res; 1994 Nov; 665(1):33-8. PubMed ID: 7882015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of ETB receptors mediating contractions induced by endothelin-1 or IRL 1620 in guinea-pig isolated airways: effects of BQ-123, FR139317 or PD 145065.
    Battistini B; Warner TD; Fournier A; Vane JR
    Br J Pharmacol; 1994 Apr; 111(4):1009-16. PubMed ID: 8032583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium.
    Molenaar P; O'Reilly G; Sharkey A; Kuc RE; Harding DP; Plumpton C; Gresham GA; Davenport AP
    Circ Res; 1993 Mar; 72(3):526-38. PubMed ID: 7679333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.